News

JMBS offers high-yield agency MBS exposure with lower volatility than junk bonds and upside from falling rates. Learn why JMBS ETF is a strong buy.
Imagine a world without disease. Sounds utopian? AI just made it a multibillion-dollar bet to discover drugs – and forget Big Pharma, Big Tech is all in on it, finds Satyen K. Bordoloi. In February ...